This presentation answers the following questions!!
How Immune Cells communicate with each other?
Receptors of Immune System?
Receptors of Innate Immune System?
What are PRRS?
What are PAMPS?
What are DAMPS?
What is the structure of PRRS?
What is the mechanism of PRRS?
What are the types of PRRS?
What is the role of PRRS in Immunology?
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
cytokines play a key role in controlling the immune system. It facilitate other cells and organs to work, with this presentation you will be able to learn about what are cytokines, their types, & their biological roles along with diseases related to cytokines and cytokines based therapies.
Evaluation and importance of innate & adaptive immunity Dr. ihsan edan ab...dr.Ihsan alsaimary
Dr. ihsan edan abdulkareem alsaimary
PROFESSOR IN MEDICAL MICROBIOLOGY AND MOLECULAR IMMUNOLOGY
ihsanalsaimary@gmail.com
mobile : 009647801410838
university of basrah - college of medicine - basrah -IRAQ
introduction of adaptive immunity. classification of adaptive immunity, factor affecting it and mechanism of adaptive immunity comparison between adaptive immunity and innate immunity. characteristic of adaptive immunity . cell mediated immune responses immunoglobulins
types of immunoglobulins. functions of immunoglobulins, hypersensitivity reactions
cytokines play a key role in controlling the immune system. It facilitate other cells and organs to work, with this presentation you will be able to learn about what are cytokines, their types, & their biological roles along with diseases related to cytokines and cytokines based therapies.
Evaluation and importance of innate & adaptive immunity Dr. ihsan edan ab...dr.Ihsan alsaimary
Dr. ihsan edan abdulkareem alsaimary
PROFESSOR IN MEDICAL MICROBIOLOGY AND MOLECULAR IMMUNOLOGY
ihsanalsaimary@gmail.com
mobile : 009647801410838
university of basrah - college of medicine - basrah -IRAQ
Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate immune system. They are single-spanning receptors usually expressed on sentinel cells such as macrophages and that recognize structurally conserved molecules derived from microbes. TLRs are pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). PAMPs are molecular structures associated with pathogens, such as bacteria, viruses, and fungi, that are recognized by the innate immune system. DAMPs are molecules that are released into the extracellular space when cells are injured or damaged. TLRs play a crucial role in the recognition of PAMPs and DAMPs and the initiation of immune responses, such as the production of pro-inflammatory cytokines, type I interferons, and other molecules that enhance the immune response. TLRs are a bridge between the innate and adaptive immune systems by regulating the activation of antigen-presenting cells and key cytokines. Upon recognition of their specific ligands, TLRs initiate downstream signaling cascades, leading to the production of pro-inflammatory and antiviral factors and the upregulation of co-stimulatory molecules, promoting the maturation of antigen-presenting cells and linking innate immunity to adaptive immunity. TLRs are widely distributed in both immune and other body cells and are a critical target for the development of immunotherapies and vaccines. Further research is needed to fully understand the .mechanisms underlying TLR signaling and its potential applications in the field of immunology.Toll-like receptors (TLRs) are a bridge between the innate and adaptive immune systems. TLRs are expressed on all innate immune cells and a large majority of non-hematopoietic cells, such as macrophages, neutrophils, dendritic cells, natural killer cells, mast cells, basophils, eosinophils, and epithelial cells. Importantly, TLRs can also be detected on adaptive immune cells, including T and B cells. Adaptive immunity consists of humoral immunity and cell-mediated immunity, which are mainly mediated by B lymphocytes and T lymphocytes, respectively. TLRs critically link innate immunity to adaptive immunity by regulating the activation of antigen-presenting cells and key cytokines. Upon recognition of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) by TLRs, downstream signaling cascades are initiated, leading to the production of pro-inflammatory cytokines, such as IL-6 and INF-α, and the upregulation of co-stimulatory molecules, promoting the maturation of antigen-presenting cells and linking innate immunity to adaptive immunity. TLR signaling is also being studied for its direct regulatory roles in effector T cells and regulatory T cells, as well as its involvement in various diseases, including infectious diseases, autoimmune conditions, and cancer.
Immunity is the ability of the body to defend itself against disease-causing organisms.
The immune system refers to a collection of cells, chemicals and processes that function to protect the body from foreign antigens, such as microbes (organisms, such as bacteria, fungi, and parasites), viruses, cancer cells, and toxins.
The structural and chemical barriers which protect us from infection, the immune system can be classified into two “lines of defense”: innate immunity and adaptive immunity
Pattern recognition receptors are type of receptors that plays a major role in innate immunity by recognizing conserved molecular components of the pathogen called pathogens- associated molecular patterns (PAMPs).There are different kinds of PRRS such as soluble pattern recognition receptors and membrane associated PRRs that recognises different kinds of PAMPs such as Carbohydrates,Proteins, lipids and nucleic acids and thereby eliminating the pathogen through different mechanisms.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
6. Ligand
Receptor
Receptors are specialized proteins located on
the surface or within cells that are capable of
recognizing and binding to specific molecules,
such as hormones, neurotransmitters, antigens,
or other signaling molecules.
They play critical roles in various biological
processes by initiating cellular responses upon
ligand binding.
9. IMMUNE
RECOGITION
& RESPONSE
The immune system is our body's defense network
against a wide array of pathogens, including
bacteria, viruses, fungi, parasites etc, that seek to
invade and harm the body.
Immune recognition (detection of threats)
Immune response (activation of defense
mechanisms)
Challenges of immune system includes
elimination of antigen and communication with
other immune cells
12. Adaptive immunity is the third line of defense and provides a slow, specific response to any
foreign invader.
It is known as Specific Recognition as the recognition is against specific antigens unique to
individual pathogens or foreign substances.
It includes two type of responses
Humoral Response or Antibody-mediated Response on B-cells
Cell mediated Response on T-cells
13. T-CELL RECEPTORS
Cells: T-Cells
Receptors: TCR (T-Cell Receptors)
Nature of Receptors: Always membrane bounded
Human T- cell (From SEM) Binding of T-cell receptor with Antigen
Structure of T- cell Receptor
18. Innate immunity is the first line of defense and provides a rapid, non-specific response to any
foreign invader.
Innate immune system includes all aspects of the host’s immune defense mechanisms that are
encoded in their mature functional forms by the germ-line genes of the host.
These include Barrier Defense (First Line of Defense)
Internal Defense (Second Line of Defense)
20. Pattern Recognition Receptors (PRRs) are a class of
proteins that play a crucial role in the innate immune
system's ability to detect and respond to pathogens.
PRRs are specialized in recognizing conserved
molecular patterns, known as Pathogen-Associated
Molecular Patterns (PAMPs), which are commonly
found on the surface of various microorganisms.
26. Extracellular Domain:
Many PRRs have an extracellular domain that is
responsible for ligand recognition.
Transmembrane Domain:
PRRs that are located on the cell surface or within
endosomes typically have a transmembrane
domain that anchors them to the cell membrane.
Cytoplasmic Domain:
The cytoplasmic domain of PRRs is involved in
signal transduction following ligand binding.
30. Pathogen-Associated Molecular Patterns (PAMPs) are conserved molecular structures
commonly found on pathogens but not on host cells.
These patterns are recognized by Pattern Recognition Receptors (PRRs) of the innate
immune system, triggering immune responses aimed at eliminating the invading
pathogens.
PAMPs are essential components of the host-pathogen interaction and play a crucial
role in the initiation of the innate immune response.
33. Damaged-Associated Molecular Patterns (DAMPs)
are endogenous molecules that are released by
stressed, injured, necrotic or dying cells.
These patterns are also recognized by Pattern
Recognition Receptors (PRRs) of the innate immune
system, triggering immune responses ad alerting the
presence of cellular damage or stress.
For example intracellular DNA, RNA can act as
DAMP when released into extracellular space.
35. Recognition and Binding of Pathogen-Associated Molecular Patterns (PAMPs)
• PRRs recognize specific molecular patterns known as PAMPs, which are commonly found on pathogens
but are absent or rare in host cells.
Activation and Signaling
• Upon binding to their specific ligands (PAMPs), PRRs undergo conformational changes that lead to the
activation of downstream signaling pathways.
• This activation triggers a series of intracellular events, including the recruitment of adaptor proteins and
the activation of transcription factors like NF-κB and IRFs (interferon regulatory factors).
36. Cytokine and Chemokine Production
• Activated PRRs induce the production of pro-inflammatory cytokines (e.g., interleukins, tumor
necrosis factor) and chemokines that orchestrate the recruitment and activation of immune cells to
the site of infection.
• These mediators amplify the immune response and coordinate the elimination of pathogens.
Antimicrobial Responses
• PRR activation leads to the induction of antimicrobial mechanisms, such as the production of
antimicrobial peptides, reactive oxygen species (ROS), and nitric oxide (NO), which directly target
and kill pathogens.
Inflammatory Responses
• PRR activation also contributes to the initiation of inflammation, which is a crucial component of
the immune response against pathogens.
• Inflammation helps to contain and eliminate the infection but must be carefully regulated to avoid
excessive tissue damage.
Linking Innate and Adaptive Immunity
• PRR activation bridges the innate and adaptive immune responses by influencing antigen
presentation, co-stimulatory molecule expression, and cytokine production, which are essential for
the activation and regulation of adaptive immune cells (e.g., T and B lymphocytes).
41. Discovered 1st in the family of PRR in Drosophila.
It is a pattern recognition molecule of innate immune system.
STRUCTURE:
NATURE: Type I transmembrane proteins
DOMAINS:
N-terminal domain (NTD):
Located outside the membrane
Middle single helix transmembrane domain:
Traverses the membrane
C-terminal domain (CTD):
Located towards the cytoplasm
43. LIGAND: It recognizes Peptidoglycan, Flagellin, viral nucleic acids (RNA and DNA), lipoproteins, and
other microbial components.
RESPONSE: Upon ligand binding, TLRs initiate signaling cascades leading to the activation of
transcription factors like NF-κB and IRF3/7 that results in the production of pro-inflammatory cytokines,
type I interferons, and other molecules that mediate the immune response.
45. It is a pattern recognition molecule of innate
immune system.
STRUCTURE: CLRs are a diverse group of
proteins characterized by the presence of one or
more C-type lectin-like domains (CTLDs),
which are involved in carbohydrate recognition.
.
46. PRESENCE: Expressed on plasma
membrane of various immune cells.
TYPES: CLRs can be further classified
based on their structure and function into
several subgroups, including simple CLRs,
transmembrane CLRs, and soluble CLRs
47. LIGAND: CLRs recognize a wide
range of carbohydrate structures,
including mannose, fructose, and
galactose residues present on
pathogens (PAMPs) and self-antigens.
Some CLRs can also recognize
glycosylated proteins and lipids.
RESPONSE: Upon ligand binding,
CLRs can trigger various immune
responses, including phagocytosis,
cytokine production, antigen
presentation, and modulation of
immune cell activation and
differentiation.
49. It is a pattern recognition molecule of innate immune system.
STRUCTURE: NLRs are characterized by the presence of a central nucleotide-
binding and oligomerization domain (NACHT), which is involved in oligomerization
and signaling.
They also contain leucine-rich repeats (LRRs) at the C-terminus, which are
responsible for ligand recognition, and a variable N-terminal effector domain that
determines their downstream signaling functions.
.
50. PRESENCE: Cytoplasmic receptors
LIGAND & RESPONSE: NLRs play a
crucial role in the recognition of
intracellular pathogens, as well as in the
sensing of endogenous danger signals.
Upon activation by microbial
components or cellular stress signals,
NLRs can oligomerize and initiate
signaling cascades that lead to the
production of inflammatory cytokines
and the induction of antimicrobial
responses.
55. Detection of Pathogens
Initiation of Immune Responses
Linking Innate and Adaptive Immunity
Tolerance and Autoimmunity
Tissue Repair and Resolution of Inflammation